Skip to main content
logo
Isofol Medical AB (publ) (FRA:5IU)
Germany flag Germany · Delayed Price · Currency is EUR
0.0500
-0.0020 (-3.85%)
At close: Jan 27, 2026

Isofol Medical AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
--0.7212.822.4137.12
Revenue
--0.7212.822.4137.12
Revenue Growth (YoY)
---94.37%-42.89%-39.63%-
Cost of Revenue
41.9138.7335.14143.71196.71199.54
Gross Profit
-41.91-38.73-34.42-130.92-174.31-162.42
Selling, General & Admin
148.487.4234.7527.7222.74
Other Operating Expenses
-0.01-0.01-0.191.810.84-0.43
Operating Expenses
13.998.487.2736.6330.1624.08
Operating Income
-55.9-47.21-41.68-167.54-204.47-186.5
Interest Expense
-0--0.01--0.17-0.15
Interest & Investment Income
1.93.724.570.150.010
Currency Exchange Gain (Loss)
-0.5-0.053.790.84-0.33
Other Non Operating Income (Expenses)
-0--3.813.53-2.01
EBT Excluding Unusual Items
-54.49-43.49-37.07-159.79-200.25-188.99
Pretax Income
-54.49-43.49-37.07-159.79-200.25-188.99
Income Tax Expense
-----0
Net Income
-54.49-43.49-37.07-159.79-200.25-188.99
Net Income to Common
-54.49-43.49-37.07-159.79-200.25-188.99
Shares Outstanding (Basic)
18916216216212661
Shares Outstanding (Diluted)
18916216216212661
Shares Change (YoY)
20.55%--28.55%104.40%91.76%
EPS (Basic)
-0.29-0.27-0.23-0.99-1.59-3.07
EPS (Diluted)
-0.29-0.27-0.23-0.99-1.59-3.07
Free Cash Flow
-48.84-41.99-52.54-192.68-188.43-160.27
Free Cash Flow Per Share
-0.26-0.26-0.33-1.19-1.50-2.61
Operating Margin
---5781.41%-1309.24%-912.50%-502.43%
Profit Margin
---5141.61%-1248.68%-893.70%-509.15%
Free Cash Flow Margin
---7286.55%-1505.66%-840.94%-431.77%
EBITDA
-55.89-47.21-41.65-167.48-204.39-186.3
D&A For EBITDA
000.040.070.080.2
EBIT
-55.9-47.21-41.68-167.54-204.47-186.5
Revenue as Reported
--0.7212.822.4137.14
Source: S&P Global Market Intelligence. Standard template. Financial Sources.